发明名称 |
Stabilized and lyophilized formulation of anthracycline compounds |
摘要 |
The present invention provides a lyophilized amrubicin formulation and a process thereof. In the process, the concentration of the aqueous solution before lyophilization is controlled to about 7.5 mg(potency)/mL or more. Thus, the formulation decreases the production of desaccharified compound and is stable to storage for a long period. The formulation is useful as a cancer chemotherapeutic agent. |
申请公布号 |
US8785406(B2) |
申请公布日期 |
2014.07.22 |
申请号 |
US200913322151 |
申请日期 |
2009.05.27 |
申请人 |
Dainippon Sumitomo Pharma Co., Ltd. |
发明人 |
Hirofuji Hajimu;Hashimoto Hotaka;Tanaka Kazunari |
分类号 |
A61K31/70 |
主分类号 |
A61K31/70 |
代理机构 |
Birch, Stewart, Kolasch & Birch, LLP |
代理人 |
Birch, Stewart, Kolasch & Birch, LLP |
主权项 |
1. A process for preparing a lyophilized amrubicin formulation comprising the following Steps (1) to (3):
(1) preparing an aqueous solution comprising (a) amrubicin or a pharmaceutically acceptable salt thereof and (b) L-cysteine or a salt thereof wherein the concentration of amrubicin or a pharmaceutically acceptable salt thereof is in the range of 7.5 mg(potency)/mL to 30 mg(potency)/HmL, (2) sterilizing the aqueous solution of Step (1) by filtration, and (3) lyophilizing the aqueous solution obtained in Step (2). |
地址 |
Osaka JP |